These resources were developed by the OASCN Collaborative between 2021-2022.
Relevant Didactics:
- Using your data and QI Tools for Stewardship (Kurlen Payton): Slides | Video
- PDSA for Stewardship. A Creative Endeavor (Kurlen Payton): Slides | Video
Relevant Learning Points:
Learning Point #45: Thinking systematically and objectively about differential diagnoses can minimize unwarranted use of empiric antibiotic therapy. Eg, maternal SIRS may manifest as SIRS in the baby potentially obviating the need for empiric antibiotics.
Learning Point #46: One can’t interpret a test result without considering pre-test probability.
Learning Point #47: We need different ways of thinking to mitigate and address how antibiotic overuse continues in some centers, here and nationally. Ongoing engagement of nursing and others (e.g. L&D team) and building confidence is key.
Relevant References:
Wiley KC et al. Antibiotic resistance policy and the stewardship role of the nurse. Policy Polit Nurs Pract 2019; 20:8.
Parente DM et al. Role of the pharmacist in antimicrobial stewardship. Med Clin North Am. 2018;102:929-936.
Barlam TF et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51. CDC Core Elements of Antimicrobial Stewardship, 2019
Additional Resources:
- https://pids.org/pediatric-asp-toolkit/inpatient-settings/reasons-for-inpatient-stewardship/neonatal-antibiotic-exposure/
- https://www.idstewardship.com/resources/
Ha DR et al. A multidisciplinary approach to incorporate bedside nurses into antimicrobial stewardship and infection prevention. Jt Comm J Qual Patient Saf. 2019;45(9):600-605.
Schechner V et al. Epidemiologic interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 2013;26:289-307.
